RARE financials
Ultragenyx (RARE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RARE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $673.00M | $564.00M | -$535.00M | -$575.00M | -5.83 |
| 2024 | $560.23M | $483.50M | -$535.97M | -$569.18M | -6.29 |
| 2023 | $434.25M | $389.04M | -$569.21M | -$606.64M | -8.25 |
| 2022 | $363.33M | $335.01M | -$648.92M | -$707.42M | -10.12 |
| 2021 | $351.41M | $335.40M | -$381.74M | -$454.02M | -6.70 |
| 2020 | $271.03M | $264.90M | -$330.12M | -$186.57M | -3.07 |
- RARE revenue was $673.00M in fiscal 2025, net income -$575.00M.
Updated 2026-11-03 02:03 UTC